Delivery Method: Via Email Product: Animal & Veterinary Drugs Recipient: Recipient Name John V. O’Keefe III, Founder - CEO Recipient Title Aaron A. Argueta, Co-Founder Bailey’s Wellness, LLC dba Bailey’s CBD (b)(6) United States info@baileyscbd.com …
COMPANY ANNOUNCEMENT When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. Read Announcement View Product Photos …
COMPANY ANNOUNCEMENT When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. Read Announcement View Product Photos …
COMPANY ANNOUNCEMENT When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. Read Announcement View Product Photos …
The Food and Drug Administration is advising consumers not to purchase or use Artrifan King, a product promoted and sold for joint pain on various websites, including www.artriking.us, and possibly in some retail stores. FDA laboratory analysis confirmed …
COMPANY ANNOUNCEMENT When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. Read Announcement View Product Photos …
COMPANY ANNOUNCEMENT When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. Read Announcement View Product Photos …
On April 23, 2025, the Food and Drug Administration approved penpulimab-kcqx (Akeso Biopharma Co., Ltd.) with cisplatin or carboplatin and gemcitabine for the first-line treatment of adults with recurrent or metastatic non-keratinizing nasopharyngeal …
The Food and Drug Administration is advising consumers not to purchase or use Painflex Forte, a product promoted and sold for joint pain on various websites, including ibspot.com and possibly in some retail stores. FDA laboratory analysis confirmed that …
For Immediate Release: April 22, 2025 The U.S. Department of Health and Human Services and U.S. Food and Drug Administration (FDA) today announced a series of new measures to phase out all petroleum-based synthetic dyes from the nation’s food supply—a …
FDA has become aware of reports of adverse events involving compounded topical finasteride products potentially putting consumers at risk. The agency is aware of some compounders and telemedicine platforms that market topical formulations of finasteride …
COMPANY ANNOUNCEMENT When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. Read Announcement View Product Photos …
COMPANY ANNOUNCEMENT When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. Read Announcement View Product Photos …
For Immediate Release: April 17, 2025 In keeping with U.S. Department of Health and Human Services Secretary Robert F. Kennedy Jr.’s promise to carry out the Department’s work with “radical transparency” and mitigate perceived industry influence and …
After much consideration, we are postponing the Interested Parties Meeting: Implementation of the Best Pharmaceuticals for Children Act and Pediatric Research Equity Act and will reschedule it to occur in the coming months. This meeting is important to all …
COMPANY ANNOUNCEMENT When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. Read Announcement View Product Photos …
Delivery Method: VIA UPS Reference #: 320-25-62 Product: Drugs Recipient: Recipient Name Ms. Lina M. Kennedy Recipient Title President and CEO PMS4PMS, LLC 4255 Research Pkwy Clarence, NY 14031-2032 United States Issuing Office: Center for Drug Evaluation …
Delivery Method: Via Email Product: Drugs WARNING LETTER March 26, 2024 RE: 701480 Dear Andy Garcia: This letter is to advise you that the United States Food and Drug Administration (FDA) reviewed your website at the Internet address https://naturistastore …
Background This procedure is intended to assist manufacturers of vaccines and other biological products to electronically submit post marketing lot distribution data to FDA under 21 CFR 600.81. Most manufacturers have submitted biological product lot …
COMPANY ANNOUNCEMENT When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. Read Announcement View Product Photos …
